Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sitbon (Paris, France), K. Chin (Texas, United States of America), R. Channick (Massachusetts, United States of America), L. Di Scala (Allschwil, Switzerland), S. Gaine (Dublin, Ireland), H. Ghofrani (London, United Kingdom), I. Lang (Vienna, Austria), V. Mclaughlin (Michigan, United States of America), R. Preiss (Allschwil, Switzerland), L. Rubin (California, United States of America), G. Simonneau (Paris, France), V. Tapson (California, United States of America), N. Galiè (Bologna, Italy), M. Hoeper (Hannover, Germany). Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study. 268

Member's Comments

No comment yet.

Related content which might interest you: Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1800279; 10.1183/13993003.00279-2018 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir J, 51 (3) 1702606; 10.1183/13993003.02606-2017 Year: 2018 Risk assessment in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 390-398 Year: 2016 Risk stratification in pulmonary arterial hypertension (PAH) Source: International Congress 2018 – New trends in the management of pulmonary hypertension Year: 2018 Childhood pulmonary arterial hypertension: Insights from REVEAL Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Risk status at selexipag initiation in pulmonary arterial hypertension (PAH): Insights from EXPOSURE Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk stratification and medical therapy of pulmonary arterial hypertension Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018 Year: 2019 Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017 Year: 2017 Pregnancy and pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018 Variation in mortality from pulmonary hypertension by aetiology Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Epidemiological and Clinical aspects of pulmonary arterial hypertension (PAH) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Molecular study of genetic modifiers in patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Risk stratification in pulmonary arterial hypertension using Bayesian analysis Source: Eur Respir J, 56 (2) 2000008; 10.1183/13993003.00008-2020 Year: 2020 An epidemiological study of pulmonary arterial hypertension in Japan Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN Source: Eur Respir J 2015; 46: 1711-1720 Year: 2015 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013